Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination - Response from the Manufacturer
N Engl J Med
.
2021 May 20;384(20):1965-1966.
doi: 10.1056/NEJMc2106075.
Epub 2021 Apr 16.
Authors
Jerald Sadoff
1
,
Kourtney Davis
1
,
Macaya Douoguih
1
Affiliation
1
Janssen Vaccines and Prevention, Leiden, the Netherlands mdouogui@its.jnj.com.
PMID:
33861522
PMCID:
PMC8117965
DOI:
10.1056/NEJMc2106075
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Neutralizing
Humans
Thrombocytopenia*
Vaccination*
Substances
Antibodies, Neutralizing